A Double-Blind, Randomized, Placebo-Controlled Phase 3 Study of Orally administered PLX3397 in Subjects with Pigmented Villonodular Synovitis or Giant Cell Tumor of the Tendon Sheath

Administered By

Awarded By

Contributors

Start/End

  • August 1, 2015 - July 31, 2021